(Circulation. 2000;102:3068.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
Sympathetic Activation by Sildenafil
From the Division of Clinical and Administrative Pharmacy (B.G.P., M.K.) and the Department of Internal Medicine (C.A.P.), University of Iowa, Iowa City; the Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland (K.N.); and the Divisions of Hypertension and Cardiovascular Diseases, Mayo Clinic, Rochester, Minn (M.W., D.D., V.K.S.).
Correspondence to Virend K. Somers, MD, PhD, Divisions of Hypertension and Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905. E-mail somers.virend{at}mayo.edu
Background—Sildenafil citrate is an effective and widely prescribed therapy for erectile dysfunction. Little is known about the effects of sildenafil on neural control of the circulation or about the effects of sildenafil on neurocirculatory stress responses.
Methods and Results—We studied 14 normal volunteers (age 32±7 years) who were randomized in a double-blind crossover fashion to receive a single oral dose of sildenafil 100 mg or placebo on 2 separate study days. Blood pressure, heart rate, forearm vascular resistance, muscle sympathetic nerve activity, and plasma catecholamines were measured at baseline and at 30 and 60 minutes after sildenafil and after placebo administration. The effects of sildenafil and placebo on neural and circulatory responses to stressful stimuli (sustained handgrip, maximal forearm ischemia, mental stress, and the cold pressor test) were also evaluated. Blood pressure, heart rate, and forearm vascular resistance after sildenafil and placebo were similar. However, muscle sympathetic nerve activity increased strikingly after sildenafil (by 141±26%, mean±SEM) compared with placebo (3±8%) (P=0.006); plasma norepinephrine levels also increased by 31±5% after sildenafil administration (P=0.004). Sympathetic nerve traffic during mental, physical, and cold stresses was 2- to 8-fold higher after sildenafil than with placebo (P<0.05).
Conclusions—Sildenafil causes a marked increase in sympathetic activation, evident both at rest and during stressful stimuli. Sympathetic activation by sildenafil may have implications for understanding cardiovascular events associated with sildenafil use.
Key Words: sildenafil citrate • blood pressure • heart rate • nervous system, sympathetic • stress
This article has been cited by other articles:
 |
|
 |
|
  V. Melenovsky, H. Al-Hiti, L. Kazdova, A. Jabor, P. Syrovatka, I. Malek, J. Kettner, and J. Kautzner Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil. J. Am. Coll. Cardiol., August 11, 2009; 54(7): 595 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Reffelmann and R. A. Kloner Phosphodiesterase 5 inhibitors: are they cardioprotective? Cardiovasc Res, July 15, 2009; 83(2): 204 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Hayreh Non-arteritic anterior ischaemic optic neuropathy and phosphodiesterase-5 inhibitors Br J Ophthalmol, December 1, 2008; 92(12): 1577 - 1580. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Guazzi Clinical Use of Phosphodiesterase-5 Inhibitors in Chronic Heart Failure Circ Heart Fail, November 1, 2008; 1(4): 272 - 280. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Fazan Jr, D. A. Huber, C. A. A. Silva, V. J. Dias da Silva, M. C. O. Salgado, and H. C. Salgado Sildenafil acts on the central nervous system increasing sympathetic activity J Appl Physiol, June 1, 2008; 104(6): 1683 - 1689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nagendran, S. L. Archer, D. Soliman, V. Gurtu, R. Moudgil, A. Haromy, C. St. Aubin, L. Webster, I. M. Rebeyka, D. B. Ross, et al. Phosphodiesterase Type 5 Is Highly Expressed in the Hypertrophied Human Right Ventricle, and Acute Inhibition of Phosphodiesterase Type 5 Improves Contractility Circulation, July 17, 2007; 116(3): 238 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Al-Hesayen, J. S. Floras, and J. D. Parker The effects of intravenous sildenafil on hemodynamics and cardiac sympathetic activity in chronic human heart failure Eur J Heart Fail, December 1, 2006; 8(8): 864 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Fesler, A. Pagnamenta, B. Rondelet, F. Kerbaul, and R. Naeije Effects of sildenafil on hypoxic pulmonary vascular function in dogs J Appl Physiol, October 1, 2006; 101(4): 1085 - 1090. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Clozel, P. Hess, M. Rey, M. Iglarz, C. Binkert, and C. Qiu Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats. Experimental Biology and Medicine, June 1, 2006; 231(6): 967 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Borlaug, V. Melenovsky, T. Marhin, P. Fitzgerald, and D. A. Kass Sildenafil Inhibits {beta}-Adrenergic-Stimulated Cardiac Contractility in Humans Circulation, October 25, 2005; 112(17): 2642 - 2649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Gardiner, J. E. March, P. A. Kemp, S. A. Ballard, E. Hawkeswood, B. Hughes, and T. Bennett Hemodynamic Effects of Phosphodiesterase 5 and Angiotensin-Converting Enzyme Inhibition Alone or in Combination in Conscious SHR J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 265 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Raja and S. H. Nayak Sildenafil: Emerging Cardiovascular Indications Ann. Thorac. Surg., October 1, 2004; 78(4): 1496 - 1506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cornolo, P. Mollard, J. V. Brugniaux, P. Robach, and J.-P. Richalet Autonomic control of the cardiovascular system during acclimatization to high altitude: effects of sildenafil J Appl Physiol, September 1, 2004; 97(3): 935 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Webster, E. D. Michelakis, T. Davis, and S. L. Archer Use of Sildenafil for Safe Improvement of Erectile Function and Quality of Life in Men With New York Heart Association Classes II and III Congestive Heart Failure: A Prospective, Placebo-Controlled, Double-blind Crossover Trial Arch Intern Med, March 8, 2004; 164(5): 514 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Reffelmann and R. A. Kloner Effects of sildenafil on myocardial infarct size, microvascular function, and acute ischemic left ventricular dilation Cardiovasc Res, August 1, 2003; 59(2): 441 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Reffelmann and R. A. Kloner Therapeutic Potential of Phosphodiesterase 5 Inhibition for Cardiovascular Disease Circulation, July 15, 2003; 108(2): 239 - 244. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Schalcher, K. Schad, H. P. Brunner-La Rocca, R. Schindler, E. Oechslin, C. Scharf, G. Suetsch, O. Bertel, and W. Kiowski Interaction of Sildenafil With cAMP-Mediated Vasodilation In Vivo Hypertension, November 1, 2002; 40(5): 763 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. J. Halcox, K. R. A. Nour, G. Zalos, R. Mincemoyer, M. A. Waclawiw, C. E. Rivera, G. Willie, S. Ellahham, and A. A. Quyyumi The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1232 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Chiu and I. A. Reid Effect of Sildenafil on Renin Secretion in Human Subjects Experimental Biology and Medicine, September 1, 2002; 227(8): 620 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Y. Yoo, H. S. Kim, J.-D. Moon, and J. Lee Sildenafil (Viagra(R)) Augments Sodium Nitroprusside-Induced But Not Nitroglycerin-Induced Hypotension in Dogs Anesth. Analg., June 1, 2002; 94(6): 1505 - 1509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Michelakis, W. Tymchak, D. Lien, L. Webster, K. Hashimoto, and S. Archer Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension: Comparison With Inhaled Nitric Oxide Circulation, May 21, 2002; 105(20): 2398 - 2403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Agelink, H. Ullrich, N. H. Brockmeyer, B. G. Phillips, M. Kato, C. Pesek, K. Narkiewicz, M. Winnicki, D. Davison, and V. Somers Sildenafil Does Not Influence Autonomic Neurocardiac Control Assessed by Standard Measurements of Heart Rate Variability Circulation, December 11, 2001; 104 (24): e145 - e145. [Full Text] [PDF]
|
|
|
|
|
|
S. D. Katz, D. V. Parums, B. G. Phillips, M. Kato, C. A. Pesek, V. K. Somers, M. Winnicki, D. Davison, and K. Narkiewicz Sympathetic Activation by Sildenafil Response Circulation, November 27, 2001; 104 (22): e119 - e120. [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Morgan, M. Alhatou, J. Oberlies, and K. C. Johnston Transient ischemic attack and stroke associated with sildenafil (Viagra) use Neurology, November 13, 2001; 57(9): 1730 - 1731. [Full Text] [PDF]
|
|
|
|
|
|
H. Wilkens, A. Guth, J. Konig, N. Forestier, B. Cremers, B. Hennen, M. Bohm, and G. W. Sybrecht Effect of Inhaled Iloprost Plus Oral Sildenafil in Patients With Primary Pulmonary Hypertension Circulation, September 11, 2001; 104(11): 1218 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Sildenafil Dramatically Increases Sympathetic Activation Journal Watch Cardiology, March 2, 2001; 2001(302): 8 - 8. [Full Text]
|
|